当前位置:首页 - 行情中心 - 南微医学(688029) - 财务分析

南微医学

(688029)

  

流通市值:157.04亿  总市值:157.04亿
流通股本:1.88亿   总股本:1.88亿

南微医学(688029)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润5.30亿元,每股收益2.72元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益424377.35万元,未分配利润189312.33万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产519241.22万元,负债94863.87万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,380,540,402.291,565,377,051.9699,156,940.32,755,434,907.16
营业总成本1,755,895,594.021,114,540,760.78501,585,822.522,064,317,241.62
其他经营收益
营业利润626,310,214.27450,832,193.49197,938,915.61659,411,813.09
利润总额626,627,247.01449,720,708.02197,789,505.94659,773,354.26
净利润530,090,341.12379,758,886.04167,162,271.01568,077,232.03
每股收益
其他综合收益29,811,229.0632,508,841.479,159,697.471,494,630.66
综合收益总额559,901,570.18412,267,727.51176,321,968.48569,571,862.69
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计3,475,983,589.073,335,431,522.263,223,440,427.413,320,779,018.7
非流动资产:
非流动资产合计1,716,428,619.231,742,031,393.931,707,795,061.181,458,827,931.11
资产总计5,192,412,208.35,077,462,916.194,931,235,488.594,779,606,949.81
流动负债:
流动负债合计863,789,230.26797,599,786.74707,067,941.17806,488,497.71
非流动负债:
非流动负债合计84,849,502.0883,062,191.7280,972,240.4273,754,998.42
负债合计948,638,732.34880,661,978.46788,040,181.59880,243,496.13
所有者权益(或股东权益):
归属于母公司股东权益合计4,071,956,863.634,029,665,779.373,994,462,762.083,826,092,661.23
股东权益合计4,243,773,475.964,196,800,937.734,143,195,3073,899,363,453.68
负债和股东权益合计5,192,412,208.35,077,462,916.194,931,235,488.594,779,606,949.81
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,566,433,223.221,716,779,893.13764,204,278.582,832,647,112.98
经营活动现金流出小计2,088,904,722.761,414,597,441.41693,637,180.932,219,625,224.9
经营活动产生的现金流量净额477,528,500.46302,182,451.7270,567,097.65613,021,888.08
投资活动产生的现金流量:
投资活动现金流入小计940,416,025.24539,693,248.52301,639,221.672,167,204,313.35
投资活动现金流出小计1,042,558,227.7549,679,260.3382,747,050.071,754,836,597.56
投资活动产生的现金流量净额-102,142,202.46-9,986,011.78-81,107,828.4412,367,715.79
筹资活动产生的现金流量:
筹资活动现金流入小计198,000,002.872,785,602.8--
筹资活动现金流出小计387,997,687.53282,338,775.6418,297,618.67357,481,298.67
筹资活动产生的现金流量净额-189,997,684.73-209,553,172.84-18,297,618.67-357,481,298.67
汇率变动对现金及现金等价物的影响30,364,694.2857,358,248.0813,594,512.6-6,954,827.84
现金及现金等价物净增加额215,753,307.55140,001,515.18-15,243,836.82660,953,477.36
期末现金及现金等价物余额2,085,969,445.752,010,217,653.381,854,972,301.381,870,216,138.2
补充资料:
现金及现金等价物的净增加额-140,001,515.18-660,953,477.36
最新报告期:2025-11-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投刘慧彬,王在存,贺菊颖3.464.034.642025-11-11
兴业证券东楠,孙媛媛,黄翰漾3.464.154.972025-11-06
中泰证券谢木青3.414.155.152025-10-28
光大证券吴佳青,王明瑞3.474.074.942025-10-28
华泰证券代雯,孔垂岩,王殷杰3.404.104.882025-10-28
TOP↑